Chipper Jones expected to miss rest of weekend with calf contusion

3 Comments

According to Chris Girandola of MLB.com, Chipper Jones is expected to miss the rest of the weekend series against the Rays after leaving last night’s game with a left calf contusion.

Jones suffered the injury when he was smacked in the left leg with a line drive off the bat of B.J. Upton while playing third base in the bottom of the second inning. He stayed in for two more at-bats before Juan Francisco pinch-hit for him in the top of the eighth.

Jones doesn’t think he needs an MRI or X-rays, but he likely won’t return to action until at least Monday when the Braves take on the Reds in Cincinnati.

“It’s safe to say my career in Tampa Bay is officially over,” said Jones, who had planned to have family and friends from his hometown area in Deland, Fla., attend the game on Saturday.

Jones, who turned 40 last month, is hitting .307/.372/.485 with five home runs, 24 RBI and an .857 OPS through 113 plate appearances this season.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.